Navigation Links
Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results
Date:5/11/2011

321649 Litigation settlement (g)

-866 Pro-forma full period effect of acquisition EBITDA (a)

3,000- Pro-forma Adjusted EBITDA (1) $
31,172$
25,733 Pro-forma Adjusted EBITDA as a percentage of  total pro-forma revenues

18.9%19.1%(1) Pro-forma Adjusted EBITDA is defined as income (loss) before interest expense (net of interest income), income taxes, depreciation and amortization, foreign currency hedge loss, gain on fair value adjustment of previously held equity investment management fees from our sponsor, non-cash expenses including costs relating to stock compensation, amortization of straight-line rent and amortization of capital expenditures relating to repairs and maintenance, sale-lease back adjustments, acquisition-related costs, other expenses including loss on sale of assets, severance payments related to termination of employee staff reductions and tail premiums on termed physicians, litigation settlements with physicians, change in accounting estimate physician compensation and pro-forma full period effect of acquisition EBITDA. (a) Pro-forma amounts related to adjustments to total revenues and Pro-forma Adjusted EBITDA to reflect the full period effect of our acquisition completed during 2011, including the purchase of the Medical Developers' physician practices in March 2011.  The adjustments reflect the impact to our total revenues and Pro-forma Adjusted EBITDA as if the acquisition had occurred at the beginning of the year. (b) Management fees are fees paid to our sponsor, Vestar Capital Partners. (c) Non-cash expenses including costs relating to stock compensation, amortization of straight-line rent and amortization of capital expenditures relating to warranty arrangements amortized to repairs and maintenance. (d) Sale-lease back adjustments relates to the adjustment of benefit derived from the classification of operating leases as finance obligations reflecting a reclassification of interest expense and depreci
'/>"/>

SOURCE Radiation Therapy Services Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. The ARIA® for Radiation Oncology Information System from Varian Medical Systems Now Certified by Surescripts® for E-Prescribing
2. Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure
3. Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer
4. Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®
5. Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices
6. Nottingham University Hospital is First U.K. User of Elektas Electronic Medical Record Workspace for Image Guided Radiation Therapy
7. University of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System
8. The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation
9. Radiation Therapy Services Holdings, Inc. Acquires Medical Developers, LLC
10. PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System
11. Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... Amgen (Nasdaq: AMGN ), today announced the ... privately held biotechnology company based in Woburn, Mass., with ... a novel investigational oncolytic vaccine in Phase 3 clinical ... melanoma and head and neck cancer. The acquisition was ...
... , a leader in bioinformatics software and knowledge integration, ... license for Pathway Studio ® Enterprise system that ... MedScan® text processing technology for site-wide use. Pathway Studio ... pathways and develop mechanistic rationale for disease based on ...
Cached Medicine Technology:Amgen Completes Acquisition of BioVex 2Amgen Completes Acquisition of BioVex 3Amgen Completes Acquisition of BioVex 4Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2
(Date:7/1/2015)... Tenn. (PRWEB) , ... July 01, 2015 , ... The ... held rain or shine Saturday, July 11, 2015, at 6 p.m. in Pugh Bourne ... free and includes pony rides, a petting zoo, an Elvis impersonator, a silent auction ...
(Date:7/1/2015)... Miami, Florida (PRWEB) , ... July 01, 2015 ... ... effects for society,” said lead author Lisa Stolzenberg, a Professor in FIU’s School ... on juveniles aged 12 to 17 years who participated in the National Survey ...
(Date:7/1/2015)... ... July 01, 2015 , ... Element Blue ™, ... today that it has received trademark protection for its SensorInsight® computer software platform. ... data from multiple sources providing an environment where users can view and compare ...
(Date:7/1/2015)... San Luis Obispo, CA (PRWEB) , ... July ... ... in non-surgical bunion treatment, announces their big summer sale. Customers purchasing two ... $15 with promo code "Summer15". , Bunion Bootie temporarily corrects misaligned ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... healthcare providers, has been retained to lead a national chief executive officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
Breaking Medicine News(10 mins):Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3
... the birth,of a daughter to 17-year-old actress Jamie Lynn ... issued the following,statement from CEO Sarah Brown:, "Every ... Jamie Lynn,Spears, new daughter, Maddie Briann, will be surrounded ... that is sure to now erupt, as it,did when ...
... Federal Reserve chairman Ben Bernanke,s,comments this week that ... one of the biggest challenges facing the nation, plus ... rise nearly 10 percent this,year, lend strong support to ... wellness, according to U.S. Preventive Medicine, the leader,in disease ...
... Cohera Medical Inc. today announced,that data published in ... the company,s surgical adhesive, TissuGlu, was effective in ... model., Summarized in a paper titled "Lysine-Derived ... Abdominoplasty Model," (Plast.,Reconstr. Surg. 2008; Vol. 122, Issue ...
... working to develop inexpensive paper that can destroy, deactivate ... will share their expertise with the world as the ... next week in Espoo, Finland. More than 80 science, ... will meet in the city northwest of Helsinki for ...
... proposes $2.29 billion hospice rate,cut, WASHINGTON, ... providers representing all 50 states are calling ... the Administration from slashing,the hospice reimbursement under ... millions of Americans nearing the end of,their ...
... The plant, Kalanchoe fedtschenkoi, is unique because, unlike normal plants, ... the air is cooler and more humid, making it 10 ... Scientists will use the latest next-generation DNA sequencing to analyse ... at night. , The project will generate a genome ...
Cached Medicine News:Health News:National Campaign to Prevent Teen and Unplanned Pregnancy Statement on Jamie Lynn Spears 2Health News:U.S. Preventive Medicine Views Bernanke's Comments as Strong Support for Prevention and Wellness Programs 2Health News:Data Published in Plastic and Reconstructive Surgery Show Cohera Medical's Surgical Adhesive, TissuGlu(R), Prevents Seroma Formation in Animal Abdominoplasty Model 2Health News:Data Published in Plastic and Reconstructive Surgery Show Cohera Medical's Surgical Adhesive, TissuGlu(R), Prevents Seroma Formation in Animal Abdominoplasty Model 3Health News:World research leaders gather in Finland to accelerate the development of bioactive paper 2Health News:Hospice Programs Nationwide Urge Congress to Act on Behalf of End-of Life Patients 2
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: